Johnson & Johnson (NYSE:JNJ), a global healthcare giant, finds itself at a critical juncture as it navigates a complex landscape of opportunities and challenges. The company's recent performance and ...

Johnson & Johnson (NYSE:JNJ), a global healthcare giant, continues to navigate a complex landscape of opportunities and challenges as it positions itself for long-term growth. Recent financial reports ...

Johnson Controls' growing catalog of digital solutions and efforts to increase service attachment rates should bolster top-line growth and expand operating ... We model about 6%-7% average organic ...

After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations.

To that end, 20 Forbes Business Development Council members highlight some of the best practices for turning cost challenges ...

Companies that don’t align the essential elements of their strategy won’t be able to create sufficient value for their firms ...

Johnson & Johnson (JNJ) said the company expects fiscal 2025 adjusted EPS in a range of $10.50 - $10.70, which represents a growth of 6.2%, at midpoint. Adjusted operational EPS is estimated in a ...

Experts in the air travel eco – system have called on the Nigeria Civil Aviation Authority (NCAA), to expand the scope/ template it is using for the on – going audit of active scheduled ...

Journey Strategic Wealth LLC owned about 0.29% of Johnson & Johnson worth $1,017,960,000 as of its most recent filing with the Securities and Exchange Commission.

Frick succeeds Model e Chief Operating Officer Marin Gjaja, who has been named Ford's new chief strategy officer and will ...

Paul Scholes thinks Martin Odegaard’s form would have gone up a notch if Arsenal had signed one of two players in the January transfer window. The Gunners recently suffered injuries to both ...